MEDICARE Rx 2000 ACT

Articles and editorials

Why the High Cost of Prescription Drugs Is a Problem We Can't Afford To Ignore, H5309 [28JN]

Bills and resolutions

Enact (H.R. 4680): consideration (see H. Res. 539), H5239 [27JN]

Briefs

Medicare+Choice reimbursement system: Minnesota congressional delegation, E1173-E1176 [30JN]

Letters

Provisions: Laurie M. Flynn, National Alliance for the Mentally Ill, H5359 [28JN]

Motions

Enact (H.R. 4680), H5383, H5397, H5398 [28JN]

———consideration (H. Res. 539), H5303, H5316, H5317 [28JN]

Press releases

FTC Charges Drug Manufacturers With Stifling Competition in Two Prescription Drug Markets: FTC, H5309 [28JN]

Remarks in House

Enact (H.R. 4680), H4916 [21JN], H5073, H5077, H5078, H5079 [23JN], H5088 [26JN], H5173 [27JN], H5319-H5415 [28JN], H5439, H5440, H5441, H5442 [29JN], H6781 [25JY], H7852-H7858 [19SE], H7977-H7983 [21SE], H8110 [26SE], H8745 [4OC], H9701 [11OC], H11532 [30OC], E1104 [23JN], E1159, E1162, E1172, E1179 [30JN], E1188 [10JY], E1203 [11JY]

———consideration (H. Res. 539), H5300-H5318 [28JN]

———motion to recommit, H5396 [28JN]

Federal-State relations: reduce State and local costs due to unfunded Federal mandates relative to Medicare Rx 2000 Act, H5301, H5302 [28JN]

Remarks in Senate

Enact (H.R. 4680), S6182 [29JN], S6185 [30JN]

Reports filed

Consideration of H.R. 4680, provisions: Committee on Rules (House) (H. Res. 539) (H. Rept. 106-705), H5239 [27JN]

Provisions: Committee on Ways and Means (House) (H.R. 4680) (H. Rept. 106-703), H5239 [27JN]

Rulings of the Chair

Enact (H.R. 4680), H5397 [28JN]

Texts of

H. Res. 539, consideratiion of H.R. 4680, provisions, H5300 [28JN]

H.R. 4680, provisions, H5319, H5334-H5349 [28JN]